Recent Press Releases

Sanofi to Present New Clinical Data at American Diabetes Association 74th Scientific Sessions

Sanofi to Present New Clinical Data at American Diabetes Association 74th Scientific Sessions -- New results for Toujeo(R) (insulin glargine [rDNA origin] injection, 300 U/mL; "U300")...

AbbVie Presents Results from Large Global Study of Patient Attitudes and Adherence Across Six Chronic Inflammatory Diseases

AbbVie Presents Results from Large Global Study of Patient Attitudes and Adherence Across Six Chronic Inflammatory Diseases - Findings Show Positive Association Between Adherence and Anti-TNF Therapy...

NovoEight(R) provides long-term reduction of bleeding in people with haemophilia A

NovoEight(R) provides long-term reduction of bleeding in people with haemophilia A COPENHAGEN, Denmark, May 12, 2014 (PR Newswire Europe via COMTEX) -- COPENHAGEN, Denmark, May 12, 2014 /PRNewswire/...

NovoEight(R) provides long-term reduction of bleeding in people with haemophilia A

NovoEight(R) provides long-term reduction of bleeding in people with haemophilia A COPENHAGEN, Denmark, May 12, 2014 (PR Newswire Europe via COMTEX) -- COPENHAGEN, Denmark, May 12, 2014 /PRNewswire/...

Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting

Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting Additional Data...

Merial appoints Fabian Kausche to lead Global Research & Development

- Veteran of animal health brings depth of expertise to Merial's R&D organization - LYON, France, June 10, 2014 /PRNewswire/ -- Merial, the animal health division of Sanofi, today announced...

For Patients Receiving Metformin to Treat Diabetes, Addition of Insulin Associated With Increased Risk of Death

For Patients Receiving Metformin to Treat Diabetes, Addition of Insulin Associated With Increased Risk of Death Among patients with diabetes who were receiving metformin, the addition of insulin...

MediSafe Wins Fourth Annual Qualcomm QPrize™ Venture Investment Competition

SAN FRANCISCO, June 10, 2014 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM), through its venture i

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

Key findings point to significant differences between treated and untreated people living with HIV

RESEARCH TRIANGLE PARK, N.C., <

Amgen Appoints David W. Meline Executive Vice President and Chief Financial Officer

Amgen Appoints David W. Meline Executive Vice President and Chief Financial Officer THOUSAND OAKS, Calif., June 9, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the appointment of David W....

Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors

Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors Monday, June 9, 2014 8:00 am EDT "I look forward to his continued contributions to patients,...

Allergan Board Unanimously Rejects Revised Unsolicited Proposal from Valeant

Allergan Board Unanimously Rejects Revised Unsolicited Proposal from Valeant Proposal Substantially Undervalues Allergan and Creates Significant Risks and Uncertainties for Allergan Stockholders...

Diabetes: Boehringer Ingelheim and Eli Lilly and Company Alliance to have 43 Presentations Featured at the American Diabetes Association's 74th Scientific Sessions®

Diabetes: Boehringer Ingelheim and Eli Lilly and Company Alliance to have 43 Presentations Featured at the American Diabetes Association's 74th Scientific Sessions® Data for LY2963016 (new...

Diabetes: Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 43 Presentations at the 74th American Diabetes Association Scientific Sessions®

· Data for investigational compounds LY2963016, empagliflozin and empagliflozin/linagliptin combination tablet highlight robust alliance pipeline

Lilly Diabetes Adds NASCAR Nationwide Series Driver Ryan Reed to Annual Diabetes Summer Camp Tour

Driver joins 10-year camp vet Kris Freeman to help inspire children with type 1 diabetes nationwide

INDIANAPOLIS,

Lilly to Participate in Goldman Sachs Global Healthcare Conference

INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 35

Lilly to Present New Clinical Data from Diabetes Portfolio with 76 Abstracts at the 74th American Diabetes Association Scientific Sessions®

Company to highlight late-stage pipeline molecules, including once-weekly dulaglutide and basal insulin peglispro

INDIANAPOLIS,

Amgen Appoints David W. Meline Executive Vice President and Chief Financial Officer

THOUSAND OAKS, Calif., June 9, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the appointment

Dendreon Announces Leadership Transition

John H. Johnson to Step Down as Chairman, President and CEO; Douglas G. Watson Elected Chairman SEATTLE, Jun 09, 2014 (BUSINESS WIRE) -- Dendreon Corporation DNDN -0.47% today announced that John...